175 related articles for article (PubMed ID: 17489560)
1. Modification and activation of Ras proteins by electrophilic prostanoids with different structure are site-selective.
Renedo M; Gayarre J; García-Domínguez CA; Pérez-Rodríguez A; Prieto A; Cañada FJ; Rojas JM; Pérez-Sala D
Biochemistry; 2007 Jun; 46(22):6607-16. PubMed ID: 17489560
[TBL] [Abstract][Full Text] [Related]
2. The cyclopentenone 15-deoxy-delta 12,14-prostaglandin J2 binds to and activates H-Ras.
Oliva JL; Pérez-Sala D; Castrillo A; Martínez N; Cañada FJ; Boscá L; Rojas JM
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4772-7. PubMed ID: 12684535
[TBL] [Abstract][Full Text] [Related]
3. Modification of proteins by cyclopentenone prostaglandins is differentially modulated by GSH in vitro.
Gayarre J; Avellano MI; Sánchez-Gómez FJ; Carrasco MJ; Cañada FJ; Pérez-Sala D
Ann N Y Acad Sci; 2007 Jan; 1096():78-85. PubMed ID: 17405918
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel protein targets for modification by 15-deoxy-Delta12,14-prostaglandin J2 in mesangial cells reveals multiple interactions with the cytoskeleton.
Stamatakis K; Sánchez-Gómez FJ; Pérez-Sala D
J Am Soc Nephrol; 2006 Jan; 17(1):89-98. PubMed ID: 16291835
[TBL] [Abstract][Full Text] [Related]
5. Differential selectivity of protein modification by the cyclopentenone prostaglandins PGA1 and 15-deoxy-Delta12,14-PGJ2: role of glutathione.
Gayarre J; Stamatakis K; Renedo M; Pérez-Sala D
FEBS Lett; 2005 Oct; 579(25):5803-8. PubMed ID: 16223487
[TBL] [Abstract][Full Text] [Related]
6. Study of protein targets for covalent modification by the antitumoral and anti-inflammatory prostaglandin PGA1: focus on vimentin.
Gharbi S; Garzón B; Gayarre J; Timms J; Pérez-Sala D
J Mass Spectrom; 2007 Nov; 42(11):1474-84. PubMed ID: 17960581
[TBL] [Abstract][Full Text] [Related]
7. Direct evidence for the covalent modification of glutathione-S-transferase P1-1 by electrophilic prostaglandins: implications for enzyme inactivation and cell survival.
Sánchez-Gómez FJ; Gayarre J; Avellano MI; Pérez-Sala D
Arch Biochem Biophys; 2007 Jan; 457(2):150-9. PubMed ID: 17169324
[TBL] [Abstract][Full Text] [Related]
8. Induction of reversible cysteine-targeted protein oxidation by an endogenous electrophile 15-deoxy-delta12,14-prostaglandin J2.
Ishii T; Uchida K
Chem Res Toxicol; 2004 Oct; 17(10):1313-22. PubMed ID: 15487891
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of hTERT expression plays an important role in 15-deoxy-Delta12,14-prostaglandin J2-induced apoptosis in cancer cells.
Moriai M; Tsuji N; Kobayashi D; Kuribayashi K; Watanabe N
Int J Oncol; 2009 May; 34(5):1363-72. PubMed ID: 19360348
[TBL] [Abstract][Full Text] [Related]
10. Thioredoxin as a molecular target of cyclopentenone prostaglandins.
Shibata T; Yamada T; Ishii T; Kumazawa S; Nakamura H; Masutani H; Yodoi J; Uchida K
J Biol Chem; 2003 Jul; 278(28):26046-54. PubMed ID: 12709421
[TBL] [Abstract][Full Text] [Related]
11. Cyclopentenone prostaglandin, 15-deoxy-Delta12,14-PGJ2, is metabolized by HepG2 cells via conjugation with glutathione.
Brunoldi EM; Zanoni G; Vidari G; Sasi S; Freeman ML; Milne GL; Morrow JD
Chem Res Toxicol; 2007 Oct; 20(10):1528-35. PubMed ID: 17854155
[TBL] [Abstract][Full Text] [Related]
12. Identification of actin as a 15-deoxy-Delta12,14-prostaglandin J2 target in neuroblastoma cells: mass spectrometric, computational, and functional approaches to investigate the effect on cytoskeletal derangement.
Aldini G; Carini M; Vistoli G; Shibata T; Kusano Y; Gamberoni L; Dalle-Donne I; Milzani A; Uchida K
Biochemistry; 2007 Mar; 46(10):2707-18. PubMed ID: 17297918
[TBL] [Abstract][Full Text] [Related]
13. 15-deoxy-Delta12,14-prostaglandin J2 attenuates development of cyclophosphamide-induced cystitis in rats.
Masuda H; Chancellor MB; Kihara K; Yoshimura N
Urology; 2006 Feb; 67(2):435-9. PubMed ID: 16461118
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of lipopolysaccharide-induced interleukin-10 by prostaglandin A1 in mouse peritoneal macrophages.
Kim HY; Kim JR; Kim HS
J Microbiol Biotechnol; 2008 Jun; 18(6):1170-8. PubMed ID: 18600064
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of serum constituents on apoptosis induced by the cyclopentenone prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in WISH epithelial cells.
Berry EB; Sato TA; Mitchell MD; Stewart Gilmour R; Helliwell RJ
Prostaglandins Leukot Essent Fatty Acids; 2004 Sep; 71(3):191-7. PubMed ID: 15253890
[TBL] [Abstract][Full Text] [Related]
16. Molecular recognition of 15-deoxy-delta(12,14)-prostaglandin J2 by nuclear factor-kappa B and other cellular proteins.
Pande V; Ramos MJ
Bioorg Med Chem Lett; 2005 Sep; 15(18):4057-63. PubMed ID: 16006125
[TBL] [Abstract][Full Text] [Related]
17. Prostanoids with cyclopentenone structure as tools for the characterization of electrophilic lipid-protein interactomes.
Stamatakis K; Pérez-Sala D
Ann N Y Acad Sci; 2006 Dec; 1091():548-70. PubMed ID: 17341644
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of trail gene expression by cyclopentenonic prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in T lymphocytes.
Fionda C; Nappi F; Piccoli M; Frati L; Santoni A; Cippitelli M
Mol Pharmacol; 2007 Nov; 72(5):1246-57. PubMed ID: 17673570
[TBL] [Abstract][Full Text] [Related]
19. 15-Deoxy-Δ
Kim SJ; Cho NC; Han B; Kim K; Hahn YI; Kim KP; Suh YG; Choi BY; Na HK; Surh YJ
FEBS Lett; 2021 Mar; 595(5):604-622. PubMed ID: 33452674
[TBL] [Abstract][Full Text] [Related]
20. Regulation of Nrf2-dependent gene expression by 15-deoxy-Delta12,14-prostaglandin J2.
Kansanen E; Kivelä AM; Levonen AL
Free Radic Biol Med; 2009 Nov; 47(9):1310-7. PubMed ID: 19573595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
